CALQUENCE

Identification of Calquence

No description

Google image searchProduct monograph

Active ingredient

acalabrutinib (acalabrutinib maleate), 100 MG

DIN: 02535696

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 01-MAY-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EL — Bruton's tyrosine kinase (BTK) inhibitors (ATC, ATC/DDD)
• L01EL02 — ACALABRUTINIB (ATC/DDD)

Reference brand drug: Calquence

External Links for Calquence

Search on Google

• Calquence side effects
• Calquence dosage
• acalabrutinib side effects
• acalabrutinib dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find calquence photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.